What is she best known for?
The fields of study she is best known for:
Oana Ciofu spends much of her time researching Pseudomonas aeruginosa, Microbiology, Cystic fibrosis, Biofilm and Bacteria.
Her studies deal with areas such as Phenotype, Chronic infection and Virulence as well as Pseudomonas aeruginosa.
Her studies in Microbiology integrate themes in fields like Immune system and Pseudomonadaceae.
The study incorporates disciplines such as Lung and Immunology in addition to Cystic fibrosis.
Her study in the fields of Respiratory disease under the domain of Lung overlaps with other disciplines such as 8-Hydroxy-2'-deoxyguanosine.
In her study, Multidrug tolerance is inextricably linked to Biofilm matrix, which falls within the broad field of Antibiotics.
Her most cited work include:
- Antibiotic resistance of bacterial biofilms (1802 citations)
- Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective (465 citations)
- The clinical impact of bacterial biofilms (427 citations)
What are the main themes of her work throughout her whole career to date?
Oana Ciofu mainly investigates Pseudomonas aeruginosa, Microbiology, Cystic fibrosis, Biofilm and Antibiotics.
The concepts of her Pseudomonas aeruginosa study are interwoven with issues in Pathogen, Colistin and Virulence.
As a member of one scientific family, Oana Ciofu mostly works in the field of Microbiology, focusing on Bacteria and, on occasion, Efflux.
Her study on Cystic fibrosis also encompasses disciplines like
- Immunology that connect with fields like Respiratory tract infections,
- Lung which is related to area like Bacteriology.
Her Biofilm study incorporates themes from Catalase, Antimicrobial, Pharmacodynamics and Hyperbaric oxygen.
Her study in Antibiotics is interdisciplinary in nature, drawing from both Internal medicine, Multidrug tolerance, In vivo and Drug resistance.
She most often published in these fields:
- Pseudomonas aeruginosa (81.25%)
- Microbiology (71.88%)
- Cystic fibrosis (55.47%)
What were the highlights of her more recent work (between 2015-2021)?
- Microbiology (71.88%)
- Pseudomonas aeruginosa (81.25%)
- Biofilm (35.94%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Microbiology, Pseudomonas aeruginosa, Biofilm, Cystic fibrosis and Antibiotics.
Her Microbiology research incorporates themes from Animal model, Whole genome sequencing and Chronic lung infections.
Her Pseudomonas aeruginosa research incorporates elements of Phenotype and Adjuvant.
Her study with Biofilm involves better knowledge in Bacteria.
The Cystic fibrosis study combines topics in areas such as Outcome assessment, Ceftazidime/avibactam, Lung and Immunology.
Her Antibiotics study integrates concerns from other disciplines, such as Pathogen, Combination therapy and Multidrug tolerance.
Between 2015 and 2021, her most popular works were:
- Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents-How P. aeruginosa Can Escape Antibiotics (119 citations)
- Antibiotic treatment of biofilm infections. (117 citations)
- Evolution of antibiotic resistance in biofilm and planktonic P. aeruginosa populations exposed to sub-inhibitory levels of ciprofloxacin (48 citations)
In her most recent research, the most cited papers focused on:
- Bacteria
- Gene
- Antibiotics
Oana Ciofu mainly focuses on Microbiology, Biofilm, Pseudomonas aeruginosa, Antibiotics and Cystic fibrosis.
Her research ties Multidrug tolerance and Microbiology together.
Oana Ciofu connects Biofilm with Phage therapy in her research.
Oana Ciofu focuses mostly in the field of Cystic fibrosis, narrowing it down to matters related to Immunology and, in some cases, Paranasal sinuses, Achromobacter xylosoxidans, Aztreonam and Tobramycin.
Oana Ciofu has researched Ciprofloxacin in several fields, including Pathogen, Genotype and Virulence.
Her work carried out in the field of Colistin brings together such families of science as Ceftazidime, Anaerobic exercise, In vivo and Bacteria.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
